Zoetis Inc. Proceeds and Excess Tax Benefit from Share-based Compensation
Zoetis Inc. (ZTS) reported Proceeds and Excess Tax Benefit from Share-based Compensation of -$30.00 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Notes › Compensation Related Costs
us-gaap:ProceedsAndExcessTaxBenefitFromSharebasedCompensation · last filed 2022-05-05
- Zoetis Inc. proceeds and excess tax benefit from share-based compensation for the quarter ending 2022-03-31 was -$30.00M.
- Zoetis Inc. proceeds and excess tax benefit from share-based compensation for the quarter ending 2021-12-31 was $2.00M.
- Zoetis Inc. proceeds and excess tax benefit from share-based compensation for the quarter ending 2021-09-30 was $2.00M, a 0.00% change year-over-year.
- Zoetis Inc. proceeds and excess tax benefit from share-based compensation for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- Zoetis Inc. proceeds and excess tax benefit from share-based compensation for fiscal 2021 was -$35.00M, a 275.00% decline from fiscal 2020.
- Zoetis Inc. proceeds and excess tax benefit from share-based compensation for fiscal 2020 was $20.00M, a 185.71% increase from fiscal 2019.
- Zoetis Inc. proceeds and excess tax benefit from share-based compensation for fiscal 2019 was $7.00M, a 63.16% decline from fiscal 2018.
- Zoetis Inc. proceeds and excess tax benefit from share-based compensation for fiscal 2018 was $19.00M, a 20.83% decline from fiscal 2017.
| Period end | Proceeds and Excess Tax Benefit from Share-based Compensation 3 month | Proceeds and Excess Tax Benefit from Share-based Compensation 6 month | Proceeds and Excess Tax Benefit from Share-based Compensation 9 month | Proceeds and Excess Tax Benefit from Share-based Compensation 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$30.00M 10-Q · filed 2022-05-05 | -$28.00M derived: sum of 2 quarters · filed 2022-05-05 | -$26.00M derived: sum of 3 quarters · filed 2022-05-05 | -$26.00M derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $4.00M derived: sum of 2 quarters · filed 2022-02-15 | $4.00M derived: sum of 3 quarters · filed 2022-02-15 | -$35.00M 10-K · filed 2022-02-15 |
| 2021-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.00M derived: sum of 2 quarters · filed 2021-11-04 | -$37.00M 10-Q · filed 2021-11-04 | -$40.00M derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$39.00M 10-Q · filed 2021-08-05 | -$42.00M derived: sum of 3 quarters · filed 2022-05-05 | -$40.00M derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-03-31 | -$39.00M 10-Q · filed 2022-05-05 | -$42.00M derived: sum of 2 quarters · filed 2022-05-05 | -$40.00M derived: sum of 3 quarters · filed 2022-05-05 | -$36.00M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | -$1.00M derived: sum of 2 quarters · filed 2022-02-15 | $3.00M derived: sum of 3 quarters · filed 2022-02-15 | $20.00M 10-K · filed 2022-02-15 |
| 2020-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $6.00M derived: sum of 2 quarters · filed 2021-11-04 | $23.00M 10-Q · filed 2021-11-04 | $28.00M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $21.00M 10-Q · filed 2021-08-05 | $26.00M derived: sum of 3 quarters · filed 2022-02-15 | $23.00M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $17.00M 10-Q · filed 2021-05-06 | $22.00M derived: sum of 2 quarters · filed 2022-02-15 | $19.00M derived: sum of 3 quarters · filed 2022-02-15 | $21.00M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $2.00M derived: sum of 2 quarters · filed 2022-02-15 | $4.00M derived: sum of 3 quarters · filed 2022-02-15 | $7.00M 10-K · filed 2022-02-15 |
| 2019-09-30 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$1.00M derived: sum of 2 quarters · filed 2020-11-05 | $2.00M 10-Q · filed 2020-11-05 | $7.00M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $5.00M 10-Q · filed 2020-08-06 | $10.00M derived: sum of 3 quarters · filed 2021-02-16 | $18.00M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $3.00M 10-Q · filed 2020-05-06 | $8.00M derived: sum of 2 quarters · filed 2021-02-16 | $16.00M derived: sum of 3 quarters · filed 2021-02-16 | $20.00M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $13.00M derived: sum of 2 quarters · filed 2021-02-16 | $17.00M derived: sum of 3 quarters · filed 2021-02-16 | $19.00M 10-K · filed 2021-02-16 |
| 2018-09-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $12.00M derived: sum of 2 quarters · filed 2019-11-07 | $14.00M 10-Q · filed 2019-11-07 | $18.00M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $6.00M 10-Q · filed 2019-08-06 | $10.00M derived: sum of 3 quarters · filed 2020-02-13 | $12.00M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $2.00M 10-Q · filed 2019-05-02 | $6.00M derived: sum of 2 quarters · filed 2020-02-13 | $8.00M derived: sum of 3 quarters · filed 2020-02-13 | $20.00M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $6.00M derived: sum of 2 quarters · filed 2020-02-13 | $18.00M derived: sum of 3 quarters · filed 2020-02-13 | $24.00M 10-K · filed 2020-02-13 |
| 2017-10-01 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $14.00M derived: sum of 2 quarters · filed 2018-11-01 | $20.00M 10-Q · filed 2018-11-01 | $21.00M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-07-02 | $12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $18.00M 10-Q · filed 2018-08-02 | $19.00M derived: sum of 3 quarters · filed 2019-02-14 | $26.00M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-04-02 | $6.00M 10-Q · filed 2018-05-02 | $7.00M derived: sum of 2 quarters · filed 2019-02-14 | $14.00M derived: sum of 3 quarters · filed 2019-02-14 | $28.00M derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $8.00M derived: sum of 2 quarters · filed 2019-02-14 | $22.00M derived: sum of 3 quarters · filed 2019-02-14 | $25.00M 10-K · filed 2019-02-14 |
| 2016-10-02 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $21.00M derived: sum of 2 quarters · filed 2017-11-02 | $24.00M 10-Q · filed 2017-11-02 | $31.00M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-07-03 | $14.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $17.00M 10-Q · filed 2017-08-08 | $24.00M derived: sum of 3 quarters · filed 2018-02-15 | $26.00M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-04-03 | $3.00M 10-Q · filed 2017-05-04 | $10.00M derived: sum of 2 quarters · filed 2018-02-15 | $12.00M derived: sum of 3 quarters · filed 2018-02-15 | $13.00M derived: sum of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $9.00M derived: sum of 2 quarters · filed 2018-02-15 | $10.00M derived: sum of 3 quarters · filed 2018-02-15 | $11.00M 10-K · filed 2018-02-15 |
| 2015-09-27 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $3.00M derived: sum of 2 quarters · filed 2016-11-03 | $4.00M 10-Q · filed 2016-11-03 | $4.00M derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-06-28 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $2.00M 10-Q · filed 2016-08-05 | $2.00M derived: sum of 3 quarters · filed 2017-02-16 | $3.00M derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-03-29 | $1.00M 10-Q · filed 2016-05-06 | $1.00M derived: sum of 2 quarters · filed 2017-02-16 | $2.00M derived: sum of 3 quarters · filed 2017-02-16 | $3.00M derived: sum of 4 quarters · filed 2017-02-16 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $1.00M derived: sum of 2 quarters · filed 2017-02-16 | $2.00M derived: sum of 3 quarters · filed 2017-02-16 | $2.00M 10-K · filed 2017-02-16 |
| 2014-09-28 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $2.00M derived: sum of 2 quarters · filed 2015-11-05 | $2.00M 10-Q · filed 2015-11-05 | $2.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-06-29 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $1.00M 10-Q · filed 2015-08-06 | $1.00M derived: sum of 3 quarters · filed 2016-02-24 | |
| 2014-03-30 | $0.00 10-Q · filed 2015-05-07 | $0.00 derived: sum of 2 quarters · filed 2016-02-24 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $0.00 10-K · filed 2016-02-24 | ||
| 2013-09-29 | $0.00 10-Q · filed 2014-11-10 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |